WHO Pharmaceuticals Newsletter 2003, No. 01
(2003; 12 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuREGULATORY MATTERS
Fermer ce répertoireSAFETY OF MEDICINES
Afficher le documentCYPROTERONE ACETATE - Not authorized for sole purpose of contraception
Afficher le documentEPOETIN ALFA - Subcutaneous administration and PRCA
Afficher le documentETANERCEPT - Usage with recombinant IL-1Ra increases incidence of serious infections
Afficher le documentETANERCEPT AND INFLIXIMAB - Possible association with lympho-proliferative disorders
Afficher le documentFLUORO-QUINOLONES - Reports of tendon disorders
Afficher le documentGRAPEFRUIT JUICE - Specific reports of drug interactions
Afficher le documentINDOMETACIN - Case report
Afficher le documentLEFLUNOMIDE - Update on ADR reports
Afficher le documentMICONAZOLE - Interaction with warfarin
Afficher le documentSERTRALINE - New prescribing information to advise against concomitant use with pimozide
Afficher le documentTAMOXIFEN - Increased risk of stroke, pulmonary embolism and uterine cancer
Ouvrir ce répertoire et afficher son contenuDRUGS OF CURRENT INTEREST
Ouvrir ce répertoire et afficher son contenuFEATURE
Afficher le documentEVENTS & ANNOUNCEMENTS
 

MICONAZOLE - Interaction with warfarin

Australia. The Australian Adverse Drug Reactions Advisory Committee (ADRAC) has received 18 reports involving drug interactions between miconazole oral gel (Daktarin oral gel) and warfarin with a resultant increase in INR (International Normalized Ratio) values. In 17 cases this involved a clinically significant increase in INR with values ranging between 7.5 and 18 and occurred within 1-2 weeks of starting miconazole. Withdrawal of one or both drugs was necessary in most cases; at least nine patients required vitamin K and five required treatment with fresh frozen plasma. Since miconazole is available without a prescription, both pharmacists and physicians are reminded to be vigilant to the possibility of such an interaction.

Reference:
Australian Adverse Drug Reactions Bulletin 21:14-15, Dec 2002. Available from URL: http://www.health.gov.au

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013